Vitruvias Therapeutics is recalling one lot of its 30-milligram Thyroid Tablets nationwide after testing found they could be "superpotent," potentially causing hyperthyroidism and cardiac problems.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.